BioNTech inks settlements with NIH, UPenn in COVID-19 vaccine royalty disputes

After the University of Pennsylvania and the U.S. National Institutes of Health (NIH) separately pressed BioNTech for royalties on its Pfizer-partnered COVID-19 vaccine Comirnaty, the German drugmaker has agreed to pay up to resolve the disputes.